Related references
Note: Only part of the references are listed.Nicotinic Receptor Stimulation Protects Nigral Dopaminergic Neurons in Rotenone-induced Parkinson's Disease Models
Hiroki Takeuchi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice
Masatoshi Inden et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone
Masatoshi Inden et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
GU Höglinger et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Selective vulnerability of dopaminergic neurons to microtubule depolymerization
Y Ren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
GU Höglinger et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation
TB Sherer et al.
EXPERIMENTAL NEUROLOGY (2003)
Increased striatal dopamine turnover following acute administration of rotenone to mice
C Thiffault et al.
BRAIN RESEARCH (2000)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet et al.
NATURE NEUROSCIENCE (2000)
The parkinsonian models: Invertebrates to mammals
Y Kitamura et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2000)
Share Paper
